
Policy
Latest News
Advertisement
CME Content
Advertisement


As payment reform models continue to evolve, practitioners must determine which strategy makes the most sense for their practice. Although the idea behind bundled payments may be worth considering, there are some concerns that this system could causes disruptions in oncology practices.

Patrick Gleason, PharmD, Director of Health Outcomes, Prime Therapeutics, says benefit design trends in specialty pharmacy show that the preferred specialty tier is generally a cost share of around one hundred dollars for a 30-day supply.






















Advertisement
Advertisement
Trending on AJMC
1
Newly Unveiled ACA Premiums Show 26% Average Increase Before Subsidy Expiration
2
Paul Ryan Champions Health Care Policy Reform, AI Amid Government Shutdown
3
Zanubrutinib Safe, Effective in Real-World CLL/SLL Cohort
4
Biktarvy Improves ART Persistence for People With HIV and Mental Health Disorders
5










































